Literature DB >> 17855817

Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia.

Jean-Pierre Quenot1, Sylvain Ladoire, Fabrice Devoucoux, Jean-Marc Doise, Romain Cailliod, Nicole Cunin, Hervé Aubé, Bernard Blettery, Pierre Emmanuel Charles.   

Abstract

OBJECTIVE: To determine whether the use of a nurse-implemented sedation protocol could reduce the incidence of ventilator-associated pneumonia in critically ill patients.
DESIGN: Two-phase (before-after), prospective, controlled study.
SETTING: University-affiliated, 11-bed medical intensive care unit. PATIENTS: Patients requiring mechanical ventilation for >or=48 hrs and sedative infusion with midazolam or propofol alone.
INTERVENTIONS: During the control phase, sedatives were adjusted according to the physician's decision. During the protocol phase, sedatives were adjusted according to a protocol developed by a multidisciplinary team including nurses and physicians. The protocol was based on the Cambridge scale, and sedation level was adjusted every 3 hrs by the nurses. Standard practices, including weaning from the ventilator and diagnosis of VAP, were the same during both study phases.
MEASUREMENTS AND MAIN RESULTS: A total of 423 patients were enrolled (control group, n = 226; protocol group, n = 197). The incidence of VAP was significantly lower in the protocol group compared with the control group (6% and 15%, respectively, p = .005). By univariate analysis (log-rank test), only use of a nurse-implemented protocol was significantly associated with a decrease of incidence of VAP (p < .01). A nurse-implemented protocol was found to be independently associated with a lower incidence of VAP after adjustment on Simplified Acute Physiology Score II in the multivariate Cox proportional hazards model (hazard rate, 0.81; 95% confidence interval, 0.62-0.95; p = .03). The median duration of mechanical ventilation was significantly shorter in the protocol group (4.2 days; interquartile range, 2.1-9.5) compared with the control group (8 days; interquartile range, 2.2-22.0; p = .001), representing a 52% relative reduction. Extubation failure was more frequently observed in the control group compared with the protocol group (13% and 6%, respectively, p = .01). There was no significant difference in in-hospital mortality (38% vs. 45% in the protocol vs. control group, respectively, p = .22).
CONCLUSIONS: In patients receiving mechanical ventilation and requiring sedative infusions with midazolam or propofol, the use of a nurse-implemented sedation protocol decreases the rate of VAP and the duration of mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855817     DOI: 10.1097/01.ccm.0000282733.83089.4d

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  50 in total

1.  Influence of algorithm-based analgesia and sedation in patients after sudden cardiac arrest.

Authors:  Nadine Abanador-Kamper; Lars Kamper; Judith Wolfertz; Wilfried Dinh; Petra Thürmann; Melchior Seyfarth
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

Review 2.  Healthcare-associated infection prevention in pediatric intensive care units: a review.

Authors:  N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

3.  Opioid Analgesics and the Risk of Serious Infections Among Patients With Rheumatoid Arthritis: A Self-Controlled Case Series Study.

Authors:  Andrew D Wiese; Marie R Griffin; C Michael Stein; Edward F Mitchel; Carlos G Grijalva
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

4.  Outcomes and risk factors of ventilator-associated pneumonia in neonates.

Authors:  Anucha Thatrimontrichai; Natthaka Rujeerapaiboon; Waricha Janjindamai; Supaporn Dissaneevate; Gunlawadee Maneenil; Supika Kritsaneepaiboon; Pattama Tanaanantarak
Journal:  World J Pediatr       Date:  2017-01-25       Impact factor: 2.764

Review 5.  Immunosuppressive effects of opioids--clinical relevance.

Authors:  Alexander Brack; Heike L Rittner; Christoph Stein
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

6.  Effect of an analgo-sedation protocol for neurointensive patients: a two-phase interventional non-randomized pilot study.

Authors:  Ingrid Egerod; Malene Brorsen Jensen; Suzanne Forsyth Herling; Karen-Lise Welling
Journal:  Crit Care       Date:  2010-04-19       Impact factor: 9.097

Review 7.  A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety.

Authors:  Daniel L Jackson; Clare W Proudfoot; Kimberley F Cann; Tim Walsh
Journal:  Crit Care       Date:  2010-04-09       Impact factor: 9.097

8.  Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.

Authors:  Jörg Martin; Anja Heymann; Katrin Bäsell; Ralf Baron; Rolf Biniek; Hartmut Bürkle; Peter Dall; Christine Dictus; Verena Eggers; Ingolf Eichler; Lothar Engelmann; Lars Garten; Wolfgang Hartl; Ulrike Haase; Ralf Huth; Paul Kessler; Stefan Kleinschmidt; Wolfgang Koppert; Franz-Josef Kretz; Heinz Laubenthal; Guenter Marggraf; Andreas Meiser; Edmund Neugebauer; Ulrike Neuhaus; Christian Putensen; Michael Quintel; Alexander Reske; Bernard Roth; Jens Scholz; Stefan Schröder; Dierk Schreiter; Jürgen Schüttler; Gerhard Schwarzmann; Robert Stingele; Peter Tonner; Philip Tränkle; Rolf Detlef Treede; Tomislav Trupkovic; Michael Tryba; Frank Wappler; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2010-02-02

Review 9.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

10.  Towards computerizing intensive care sedation guidelines: design of a rule-based architecture for automated execution of clinical guidelines.

Authors:  Femke Ongenae; Femke De Backere; Kristof Steurbaut; Kirsten Colpaert; Wannes Kerckhove; Johan Decruyenaere; Filip De Turck
Journal:  BMC Med Inform Decis Mak       Date:  2010-01-18       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.